The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):537-40.
Eur Rev Med Pharmacol Sci. 2013.
PMID: 23467955
Free article.